Patent · US Active

Compounds for the treatment of cancer

US11530207B2 · kind B2 · utility

0Cited by

3References

20Claims

0Family size

Assignee

SKYHAWK THERAPEUTICS, INC. · US

Inventors

Michael Joseph Luzzio · Noank, US
Kathleen McCarthy · Waltham, US

Key dates

Filing date	Apr 10, 2019
Grant date	Dec 20, 2022
Priority date	—
Expiry date	May 25, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are splice modifying compounds affecting splicing of mRNA, such as pre-mRNA, expressed from the FOXM1 gene, compositions comprising thereof, and methods using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.